Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Harris Poll Finds Large Boost in Pharma Industry Reputation

Posted on March 15th, 2021 by in Pharma R&D

As the COVID-19 vaccine roll-out gains in intensity, it has become common to hear people toss out the names of pharmaceutical companies like Pfizer, Moderna and AstraZeneca with the same ease that they refer to their favorite brands of ketchup or peanut butter. This isn’t typical. While direct-to-consumer advertising has perhaps increased some awareness of drug makers, the pandemic has made pharma R&D a subject of public interest in an unprecedented fashion.

(more…)

Harnessing big data — it’s challenging, but it can be done

Posted on February 12th, 2018 by in Pharma R&D

Rubius logo

Today’s big data has the power to drive innovation in ways that the pharmaceutical industry could previously only dream of. Yet harnessing that power comes with an equally sizable challenge: it will require an enormous shift in how research is performed. (more…)

Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle

Posted on December 22nd, 2017 by in Pharma R&D

Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. (more…)

How Pharma Can Make the Most of Gene Tech CRISPR

Posted on December 18th, 2017 by in Pharma R&D

puzzle-2500333_960_720

The gene-editing technology CRISPR, which stands for ‘clustered regularly interspaced short palindromic repeats,’ is one of today’s most-talked-about scientific innovations. In just a few years, it’s gone from being a barely known entity to becoming a regular presence in scientific literature. (more…)

  1. 1
  2. 2
  3. 3
  4. 7